{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:57:14Z","timestamp":1740149834500,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s12328-024-01967-2","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T03:26:53Z","timestamp":1714620413000},"page":"697-704","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Surgical resection of double advanced pancreatic neuroendocrine tumors with multiple renal cell carcinoma associated with von Hippel\u2013Lindau disease"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7137-7305","authenticated-orcid":false,"given":"Yoshiyuki","family":"Shibata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Sudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Tazuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Onoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanobu","family":"Shigeta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Kuraoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,2]]},"reference":[{"key":"1967_CR1","unstructured":"Syuin T. Von Hippel-Lindau disease clinical guideline.2011 CHUGAIIGAKU CO., LTD."},{"key":"1967_CR2","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","volume":"361","author":"RR Lonser","year":"2003","unstructured":"Lonser RR, Glenn GM, Walther M, et al. von Hippel-Lindau disease. Lancet. 2003;361:2059\u201367.","journal-title":"Lancet"},{"key":"1967_CR3","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.surg.2007.09.012","volume":"142","author":"JA Blansfield","year":"2007","unstructured":"Blansfield JA, Choyke L, Morita SY, et al. Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs). Surgery. 2007;142:814\u20138.","journal-title":"Surgery"},{"key":"1967_CR4","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.2214\/ajr.162.5.8165988","volume":"162","author":"DM Hough","year":"1994","unstructured":"Hough DM, Stephens DH, Johnson CD, et al. Pancreatic lesions in von Hippel-Lindau disease: prevalence, clinical significance, and CT findings. Am J Roentgenol. 1994;162:1091\u20134.","journal-title":"Am J Roentgenol"},{"key":"1967_CR5","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/01.mpa.0000240604.26312.e4","volume":"33","author":"I Yamasaki","year":"2006","unstructured":"Yamasaki I, Nishimori I, Ashida S, et al. Clinical characteristics of pancreatic neuroendocrine tumors in Japanese patients with von Hippel-Lindau disease. Pancreas. 2006;33:382\u20135.","journal-title":"Pancreas"},{"key":"1967_CR6","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1038\/modpathol.3800954","volume":"20","author":"M Volante","year":"2007","unstructured":"Volante M, Brizzi MP, Faggiano A, et al. Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy. Mod Pathol. 2007;20:1172\u201382.","journal-title":"Mod Pathol"},{"key":"1967_CR7","volume-title":"TNM Classification of Malignant Tumors","author":"JD Brierley","year":"2017","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumors. 8th ed. Ltd: John Wiley & Sons; 2017.","edition":"8"},{"key":"1967_CR8","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1056\/NEJMoa1009290","volume":"364","author":"JC Yao","year":"2011","unstructured":"Yao JC, Shah MH, Ito T, et al. Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med. 2011;364:514\u201323.","journal-title":"N Engl J Med"},{"key":"1967_CR9","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/nrendo.2010.3","volume":"6","author":"K Oberg","year":"2010","unstructured":"Oberg K. Cancer: antitumor effects of octreotide LAR, a somatostatin analog. Nat Rev Endocrinol. 2010;6:188\u20139.","journal-title":"Nat Rev Endocrinol"},{"key":"1967_CR10","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1056\/NEJMoa1316158","volume":"371","author":"ME Caplin","year":"2014","unstructured":"Caplin ME, Pavel M, \u0106wik\u0142a JB, et al. Lanreotide in metastatic enteropancreatic neuroendocrine tumors. N Engl J Med. 2014;371:224\u201333.","journal-title":"N Engl J Med"},{"key":"1967_CR11","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s12328-009-0071-2","volume":"2","author":"H Maeda","year":"2009","unstructured":"Maeda H, Nishimori I, Okabayashi T, et al. Total pancreatectomy for multiple neuroendocrine tumors of the pancreas in a patient with von Hippel-Lindau disease. Clin J Gastroenterol. 2009;2:222\u20135.","journal-title":"Clin J Gastroenterol"},{"key":"1967_CR12","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/j.1349-7006.2006.00193.x","volume":"97","author":"K Hattori","year":"2006","unstructured":"Hattori K, Teranishi J, Stolle C, et al. Detection of germline deletions using real-time quantitative polymerase chain reaction in Japanese patients with von Hippel-Lindau disease. Cancer Sci. 2006;97:400\u20135.","journal-title":"Cancer Sci"},{"key":"1967_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.108847","volume":"124","author":"B Yang","year":"2020","unstructured":"Yang B, Chen HY, Zhang XY, et al. The prognostic value of multidetector CT features in predicting overall survival outcomes in patients with pancreatic neuroendocrine tumors. Eur J Radiol. 2020;124: 108847.","journal-title":"Eur J Radiol"},{"key":"1967_CR14","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1245\/s10434-016-5663-8","volume":"24","author":"Y Nanno","year":"2017","unstructured":"Nanno Y, Matsumoto I, Zen Y, et al. Pancreatic duct involvement in well-differentiated neuroendocrine tumors is an independent poor prognostic factor. Ann Surg Oncol. 2017;24:1127\u201333.","journal-title":"Ann Surg Oncol"},{"key":"1967_CR15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s00534-005-1041-9","volume":"13","author":"A Osawa","year":"2006","unstructured":"Osawa A, Sumiyama Y, Watanabe M, et al. Single case of renal cell carcinoma and endocrine pancreatic head cancer occurring with von Hippel-Lindau disease. J Hepatobiliary Pancreat Surg. 2006;13:174\u201380.","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"1967_CR16","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.ijscr.2013.03.004","volume":"4","author":"A Addeo","year":"2013","unstructured":"Addeo A, Bini R, Viora T, et al. Von Hippel-Lindau and myotonic dystrophy of Steinert along with pancreatic neuroendocrine tumor and renal clear cell carcinomal neoplasm: case report and review of the literature. Int J Surg Case Rep. 2013;4:648\u201350.","journal-title":"Int J Surg Case Rep"},{"key":"1967_CR17","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.2169\/internalmedicine.8347-16","volume":"56","author":"H Matsubayashi","year":"2017","unstructured":"Matsubayashi H, Niwakawa M, Uesaka K, et al. Renal cell carcinoma and a pancreatic neuroendocrine tumor: a coincidence or instance of Von Hippel-Lindau Disease? Intern Med. 2017;56:2281\u20134.","journal-title":"Intern Med"},{"key":"1967_CR18","first-page":"83","volume":"38","author":"CG Woo","year":"2017","unstructured":"Woo CG, Choi SY, Kwak JJ, et al. Clear cell neuroendocrine tumor of the pancreas in von Hippel-Lindau disease: a case report and literature review. Neuro Endocrinol Lett. 2017;38:83\u20136.","journal-title":"Neuro Endocrinol Lett"},{"key":"1967_CR19","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1067\/msy.2003.146","volume":"133","author":"SM Strasberg","year":"2003","unstructured":"Strasberg SM, Drebin JA, Linehan D. Radical antegrade modular pancreatosplenectomy. Surgery. 2003;133:521\u20137.","journal-title":"Surgery"},{"key":"1967_CR20","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s003300050717","volume":"9","author":"FJ Hes","year":"1999","unstructured":"Hes FJ, Feldberg MA. Von Hippel-Lindau disease: strategies in early detection (renal-, adrenal-, pancreatic masses). Eur Radiol. 1999;9:598\u2013610.","journal-title":"Eur Radiol"},{"key":"1967_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2967\/jnumed.116.178095","volume":"58","author":"E Panagiotidis","year":"2017","unstructured":"Panagiotidis E, Alshammari A, Michopoulou S, et al. Comparison of the Impact of 68Ga-DOTATATE and 18F-FDG PET\/CT on Clinical Management in Patients with Neuroendocrine Tumors. J Nucl Med. 2017;58:91\u20136.","journal-title":"J Nucl Med"},{"key":"1967_CR22","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1007\/s12149-014-0900-3","volume":"28","author":"K Kubota","year":"2014","unstructured":"Kubota K, Okasaki M, Minamimoto R, et al. Lesion-based analysis of (18)F-FDG uptake and (111)In-Pentetreotide uptake by neuroendocrine tumors. Ann Nucl Med. 2014;28:1004\u201310.","journal-title":"Ann Nucl Med"},{"key":"1967_CR23","doi-asserted-by":"publisher","first-page":"508","DOI":"10.2967\/jnumed.106.035667","volume":"48","author":"M Gabriel","year":"2007","unstructured":"Gabriel M, Decristoforo C, Kendler D, et al. 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT. J Nucl Med. 2007;48:508\u201318.","journal-title":"J Nucl Med"},{"key":"1967_CR24","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.1002\/cncr.28341","volume":"119","author":"K Okuwaki","year":"2013","unstructured":"Okuwaki K, Kida M, Mikami T, et al. Clinicopathologic characteristics of pancreatic neuroendocrine tumors and relation of somatostatin receptor type 2A to outcomes. Cancer. 2013;119:4094\u2013102.","journal-title":"Cancer"},{"key":"1967_CR25","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001281","volume":"94","author":"S Mehta","year":"2015","unstructured":"Mehta S, de Reuver PR, Gill P, et al. Somatostatin receptor SSTR-2a expression is a stronger predictor for survival than Ki-67 in pancreatic neuroendocrine tumors. Medicine (Baltimore). 2015;94: e1281.","journal-title":"Medicine (Baltimore)"},{"key":"1967_CR26","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s002619900246","volume":"22","author":"K Hoshiba","year":"1997","unstructured":"Hoshiba K, Demachi H, Miyata S, et al. Fatty infiltration of the liver distal to a metastatic liver tumor. Abdom Imaging. 1997;22:496\u20138.","journal-title":"Abdom Imaging"},{"key":"1967_CR27","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.crad.2012.02.014","volume":"67","author":"P Borghei","year":"2012","unstructured":"Borghei P, Pan Z, Berland LL. Peritumoural steatosis in metastatic \u201cnon-functioning\u201d neuroendocrine tumour of the pancreas. Clin Radiol. 2012;67:1027\u20139.","journal-title":"Clin Radiol"},{"key":"1967_CR28","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1056\/NEJMoa1003825","volume":"364","author":"E Raymond","year":"2011","unstructured":"Raymond E, Dahan L, Raoul JL, et al. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med. 2011;364:501\u201313.","journal-title":"N Engl J Med"},{"key":"1967_CR29","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1056\/NEJM199202203260804","volume":"326","author":"CG Moertel","year":"1992","unstructured":"Moertel CG, Lefkopoulo M, Lipsitz S, et al. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma. N Engl J Med. 1992;326:519\u201323.","journal-title":"N Engl J Med"},{"key":"1967_CR30","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00280-018-3656-y","volume":"82","author":"H Shibuya","year":"2018","unstructured":"Shibuya H, Hijioka S, Sakamoto Y, et al. Multi-center clinical evaluation of streptozocin-based chemotherapy for advanced pancreatic neuroendocrine tumors in Japan: focus on weekly regimens and monotherapy. Cancer Chemother Pharmacol. 2018;82:661\u20138.","journal-title":"Cancer Chemother Pharmacol"},{"key":"1967_CR31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1056\/NEJMoa1607427","volume":"376","author":"J Strosberg","year":"2017","unstructured":"Strosberg J, El-Haddad G, Wolin E, et al. Phase 3 trial of (177)Lu-dotatate for midgut neuroendocrine tumors. N Engl J Med. 2017;376:125\u201335.","journal-title":"N Engl J Med"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-024-01967-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-024-01967-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-024-01967-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T09:07:45Z","timestamp":1722157665000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-024-01967-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,2]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["1967"],"URL":"https:\/\/doi.org\/10.1007\/s12328-024-01967-2","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"type":"print","value":"1865-7257"},{"type":"electronic","value":"1865-7265"}],"subject":[],"published":{"date-parts":[[2024,5,2]]},"assertion":[{"value":"5 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest in the present work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed in this study were performed in accordance with the ethical standards of the 1964 Declaration of Helsinki and its subsequent amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human rights"}},{"value":"Informed consent was obtained from the patient for publication of this case report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}